CODE FOR A BETTER LIFE
U.S. Patent No. 8,911,727, entitled “Monoclonal Antibody Human Non-small Cell Lung Carcinoma and Use Thereof”
U.S. Patent No. 10,444,237, entitled “Anti-Pancreatic Cancer Monoclonal Antibody and Use Thereof”
AUS Patent No. 2012331968 B2, entitled "Monoclonal antibody against human non-small-cell lung carcinoma and use thereof"
CN Patent No. 106399536A, Entitled "Body Fluid Circulation DNA Quantitative Determination Method and Kit"
CN Patent NO. CN105462935A, entitled "Monoclonal Antibody Resisting Ovarian Cancer Application Thereof"
CN Patent No. CN103439509B, entitled "Application of Specific Circulating Non-small Cell Lung Cancer Cell Marker"
CN Patent No. CN 103602678A, entitled "Non-small Cell Lung Cancer Prognosis Detection Composition and Applications Thereof"
CN Patent No. CN102944681A, entitled "Application of Non-Small Cell Lung Cancer Pleural effusion Tumor Marker"
CN Patent No. WO2013063876A1, entitled "Double Antibody Sandwiched ELISA Kit For Detecting Non-small Cell Lung cancer and Applications Thereof"
CN Patent No. CN105462935B, entitled "China Ovarian Cancer Resistance Monoclonal Antibody and Its Application"
WIPO Patent No. WO2013063874A1, entitled "Monoclonal Antibody Against Human Non-small Cell Lung Carcinoma and Use thereof"
CERTIFICATION OF QUALITY SYSTEM
ISO13485:2016 certified on October of 2019.